198 related articles for article (PubMed ID: 22486244)
1. AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.
Rosenberg JB; Hicks MJ; De BP; Pagovich O; Frenk E; Janda KD; Wee S; Koob GF; Hackett NR; Kaminsky SM; Worgall S; Tignor N; Mezey JG; Crystal RG
Hum Gene Ther; 2012 May; 23(5):451-9. PubMed ID: 22486244
[TBL] [Abstract][Full Text] [Related]
2. Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAV.
De BP; Hackett NR; Crystal RG; Boyer JL
Mol Ther; 2008 Jan; 16(1):203-9. PubMed ID: 18059375
[TBL] [Abstract][Full Text] [Related]
3. AAVrh.10-mediated genetic delivery of bevacizumab to the pleura to provide local anti-VEGF to suppress growth of metastatic lung tumors.
Watanabe M; Boyer JL; Crystal RG
Gene Ther; 2010 Aug; 17(8):1042-51. PubMed ID: 20596059
[TBL] [Abstract][Full Text] [Related]
4. Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer.
Wang G; Qiu J; Wang R; Krause A; Boyer JL; Hackett NR; Crystal RG
Cancer Gene Ther; 2010 Aug; 17(8):559-70. PubMed ID: 20448672
[TBL] [Abstract][Full Text] [Related]
5. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
[TBL] [Abstract][Full Text] [Related]
6. Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus.
Koob G; Hicks MJ; Wee S; Rosenberg JB; De BP; Kaminsky SM; Moreno A; Janda KD; Crystal RG
CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):899-904. PubMed ID: 22229312
[TBL] [Abstract][Full Text] [Related]
7. AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation.
Hicks MJ; Rosenberg JB; De BP; Pagovich OE; Young CN; Qiu JP; Kaminsky SM; Hackett NR; Worgall S; Janda KD; Davisson RL; Crystal RG
Sci Transl Med; 2012 Jun; 4(140):140ra87. PubMed ID: 22745437
[TBL] [Abstract][Full Text] [Related]
8. Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody.
Norman AB; Ball WJ
Immunotherapy; 2012 Mar; 4(3):335-43. PubMed ID: 22401638
[TBL] [Abstract][Full Text] [Related]
9. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.
Liu W; Zhao L; Blackman B; Parmar M; Wong MY; Woo T; Yu F; Chiuchiolo MJ; Sondhi D; Kaminsky SM; Crystal RG; Paul SM
J Neurosci; 2016 Dec; 36(49):12425-12435. PubMed ID: 27927959
[TBL] [Abstract][Full Text] [Related]
10. Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.
Hicks MJ; De BP; Rosenberg JB; Davidson JT; Moreno AY; Janda KD; Wee S; Koob GF; Hackett NR; Kaminsky SM; Worgall S; Toth M; Mezey JG; Crystal RG
Mol Ther; 2011 Mar; 19(3):612-9. PubMed ID: 21206484
[TBL] [Abstract][Full Text] [Related]
11. Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.
Matsumura Y; Li N; Alwaseem H; Pagovich OE; Crystal RG; Greenblatt MB; Stiles KM
Hum Gene Ther; 2020 Feb; 31(3-4):163-182. PubMed ID: 31801381
[TBL] [Abstract][Full Text] [Related]
12. Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.
Welles HC; Jennewein MF; Mason RD; Narpala S; Wang L; Cheng C; Zhang Y; Todd JP; Lifson JD; Balazs AB; Alter G; McDermott AB; Mascola JR; Roederer M
PLoS Pathog; 2018 Dec; 14(12):e1007395. PubMed ID: 30517201
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Transcriptome Analysis of Mouse Liver Cell-Specific Tropism and Transcriptional Dysregulation Following Intravenous Administration of AAVrh.10 Vectors.
Zhu D; Rostami MR; Zuo WL; Leopold PL; Crystal RG
Hum Gene Ther; 2020 May; 31(9-10):590-604. PubMed ID: 32143547
[TBL] [Abstract][Full Text] [Related]
14. High levels of persistent expression of alpha1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses.
De BP; Heguy A; Hackett NR; Ferris B; Leopold PL; Lee J; Pierre L; Gao G; Wilson JM; Crystal RG
Mol Ther; 2006 Jan; 13(1):67-76. PubMed ID: 16260185
[TBL] [Abstract][Full Text] [Related]
15. AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer.
Xie Y; Hicks MJ; Kaminsky SM; Moore MA; Crystal RG; Rafii A
Gynecol Oncol; 2014 Nov; 135(2):325-32. PubMed ID: 25108232
[TBL] [Abstract][Full Text] [Related]
16. Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine Hydrolase Gene Therapy: A Good Laboratory Practice Preclinical Study in Mice.
Chen VP; Gao Y; Geng L; Steele M; Jenks N; Peng KW; Brimijoin S
Hum Gene Ther; 2020 Jan; 31(1-2):70-79. PubMed ID: 31650869
[TBL] [Abstract][Full Text] [Related]
17. Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.
Brimijoin S
CNS Neurol Disord Drug Targets; 2011 Dec; 10(8):880-91. PubMed ID: 22229308
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2.
Markmann S; J Christie-Reid J; Rosenberg JB; De BP; Kaminsky SM; Crystal RG; Sondhi D
Exp Neurol; 2018 Aug; 306():22-33. PubMed ID: 29655638
[TBL] [Abstract][Full Text] [Related]
19. Effects of anti-cocaine vaccine and viral gene transfer of cocaine hydrolase in mice on cocaine toxicity including motor strength and liver damage.
Gao Y; Geng L; Orson F; Kinsey B; Kosten TR; Shen X; Brimijoin S
Chem Biol Interact; 2013 Mar; 203(1):208-11. PubMed ID: 22935511
[TBL] [Abstract][Full Text] [Related]
20. Cocaine vaccines: antibody protection against relapse in a rat model.
Carrera MR; Ashley JA; Zhou B; Wirsching P; Koob GF; Janda KD
Proc Natl Acad Sci U S A; 2000 May; 97(11):6202-6. PubMed ID: 10823960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
